iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,678
(-0.85%)
Jul 22, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,400₹0.15 0%51,4500%
00%₹254.8 0%1,440₹0.15 -40%53,5500%
7000%₹200 0%1,480₹0.25 66.66%2,22,6000%
7000%₹169.15 0%1,500₹0.5 11.11%4,03,9001.05%
00%₹175.8 0%1,520₹0.45 0%17,8500%
5,6000%₹156.8 0%1,540₹1.1 69.23%1,47,000-0.94%
4,9000%₹145.4 0%1,560₹1.2 33.33%69,650-3.86%
10,1500%₹134 0%1,580₹1.75 59.09%72,4502.47%
56,0000%₹97.25 -0.66%1,600₹2.4 45.45%4,09,15012.51%
90,300-0.76%₹64.75 -17.04%1,620₹3.5 59.09%2,56,90089.17%
1,23,9002.90%₹46.7 -21.97%1,640₹5.6 53.42%2,52,3503.29%
1,22,500-12.28%₹31.75 -24.4%1,660₹9.75 58.53%2,54,450-20.89%
3,49,6507.88%₹18.4 -32.72%1,680₹16.75 48.88%2,72,3002.50%
22,41,4000.21%₹8.8 -45.34%1,700₹26.95 38.91%3,73,800-18.22%
26,01,2003.79%₹3.55 -59.42%1,720₹41.8 27.63%3,67,150-9.72%
11,71,450-22.09%₹2 -62.26%1,740₹60.05 19.86%97,650-17.69%
7,60,90011.77%₹1.4 -55.55%1,760₹79.9 22.92%35,0009.89%
2,78,950-16.54%₹1.1 -51.11%1,780₹88.55 0.33%14,0000%
7,09,100-2.87%₹0.9 -47.05%1,800₹119 12.74%65,4505.64%
1,47,3505.25%₹0.85 -26.08%1,820₹93.1 0%9,8000%
2,67,750-4.61%₹0.4 -42.85%1,840₹138.35 0%4,9000%
1,03,950-4.80%₹0.25 -44.44%1,860--
2,95,0500%₹0.15 -50%1,880₹220 0%1,4000%
71,750-1.44%₹0.2 -33.33%1,920₹193 0.12%3,5000%
4,2009.09%₹0.25 -50%1,960--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 15th July 2025
15 Jul 2025|06:24 AM

Here are some of the stocks that may see significant price movement today: Power Mech Projects, Rail Vikas Nigam, Rallis India, etc.

Read More
Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.